Effects of cannabis on lung function: a population-based cohort study.
The effects of cannabis on lung function remain unclear and may be different from those of tobacco. We compared the associations between use of these substances and lung function in a population-based cohort (n = 1,037). Cannabis and tobacco use were reported at ages 18, 21, 26 and 32 yrs. Spirometry, plethysmography and carbon monoxide transfer factor were measured at 32 yrs. Associations between lung function and exposure to each substance were adjusted for exposure to the other substance. Cumulative cannabis use was associated with higher forced vital capacity, total lung capacity, functional residual capacity and residual volume. Cannabis was also associated with higher airway resistance but not with forced expiratory volume in 1 s, forced expiratory ratio or transfer factor. These findings were similar among those who did not smoke tobacco. In contrast, tobacco use was associated with lower forced expiratory volume in 1 s, lower forced expiratory ratio, lower transfer factor and higher static lung volumes, but not with airway resistance. Cannabis appears to have different effects on lung function from those of tobacco. Cannabis use was associated with higher lung volumes, suggesting hyperinflation and increased large-airways resistance, but there was little evidence for airflow obstruction or impairment of gas transfer.
Hancox
R J
RJ
Dunedin Multidisciplinary Health and Development Research Unit, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. bob.hancox@otago.ac.nz
Poulton
R
R
Ely
M
M
Welch
D
D
Taylor
D R
DR
McLachlan
C R
CR
Greene
J M
JM
Moffitt
T E
TE
Caspi
A
A
Sears
M R
MR
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008385:Marijuana Smoking / Q000503:physiopathology*; D012907:Smoking / Q000503:physiopathology*; D014109:Total Lung Capacity; D055815:Young Adult
Respirology. 2008 Jan;13(1):122-7
18197922
Thorax. 2000 Apr;55(4):340-2
10722775
Pharmacol Biochem Behav. 1991 Nov;40(3):651-6
1666923
Addiction. 2000 Nov;95(11):1669-77
11219370
Eur Respir J. 1997 Jun;10(6):1415-27
9192953
Thorax. 2009 Mar;64(3):228-32
19052051
JAMA. 2008 Feb 6;299(5):525-31
18252882
Thorax. 2007 Dec;62(12):1036-7
18025140
Addict Behav. 1988;13(2):147-50
2835893
Pharmacol Biochem Behav. 1991 Nov;40(3):657-61
1666924
N Engl J Med. 2003 Oct 9;349(15):1414-22
14534334
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):928-37
9517614
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2185-98
8520796
Am Rev Respir Dis. 1987 Jan;135(1):209-16
3492159
Chest. 1997 Aug;112(2):319-26
9266864
Arch Intern Med. 2007 Feb 12;167(3):221-8
17296876
J R Soc Med. 2006 Feb;99(2):77-80
16449781
Thorax. 2007 Dec;62(12):1058-63
17666437
Addiction. 2002 Aug;97(8):1055-61
12144608
J Chronic Dis. 1987;40(11):1013-23
3498737
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
7663792
J Clin Pharmacol. 2002 Nov;42(S1):71S-81S
12412839
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
742764
Eur J Cardiothorac Surg. 2007 Dec;32(6):834-8
17931876
N Engl J Med. 1988 Feb 11;318(6):347-51
3340105